Balchem Corporation Reports Strong Quarterly Earnings and Provides Guidance for 2026

Balchem Corporation (NASDAQ: ABCM), a leading global manufacturer of ingredients for the food, nutrition, and healthcare industries, announced its financial results for the fourth quarter of 2025. The company reported strong earnings per share (EPS) growth, driven by increased demand for its products in key markets. Net sales for the fourth quarter 2025 reached $1.53 billion, a 12% increase compared to the same period last year. The growth was primarily driven by expansion in the company’s food and human nutrition business segments. Operating income for the quarter came in at $343 million, up 15% from the previous year. The company also reported significant progress in its innovation pipeline, with several new product launches announced during the quarter. These new products are designed to address emerging trends and opportunities in the markets served by Balchem Corporation’s customers. “We are pleased with our strong quarterly results, which demonstrate the effectiveness of our strategy to drive growth and expand our presence in key markets,” said Tony Milner, President and CEO of Balchem Corporation. “We remain committed to investing in innovation and customer service, and we are confident that these efforts will continue to drive long-term value for our shareholders.” For 2026, the company is providing guidance that net sales will increase by 10% compared to 2025. This growth is expected to be driven by continued expansion in the food and human nutrition business segments, as well as new product launches and increasing demand for Balchem Corporation’s products. Balchem Corporation is a global manufacturer of ingredients with a diverse portfolio of products used in a wide range of applications, including food and beverages, animal nutrition, pharmaceuticals, and personal care. The company’s products are designed to provide unique nutritional and functional benefits that enhance the performance and well-being of consumers.